Evidence mapPaperPMID 41136513Full record

ArticleScientific reports2025

Privacy preservation in diabetic disease prediction using federated learning based on efficient cross stage recurrent model.

R Jayalakshmi, T Tamilvizhi

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

R JayalakshmiDepartment of Computer Science and Engineering, Panimalar Engineering College, Chennai, India.
T TamilvizhiDepartment of Computer Science and Engineering, Panimalar Engineering College, Chennai, India. tamilvizhi.mtech.it@gmail.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Diabetic retinopathy (DR) is a major problemfor the diabetes patients that makes a serious threat to vision and causes the irreversible blindness if not diagnosed and treated early. Conventional deep learning-based approaches designed for DR detection have demonstrated promising results; still, the requirement of centralized data aggregation makes privacy and security concerns for sharing the healthcare data. Thus, for providing the privacy preservation federated learning (FL) based methods were designed; still, the computation overhead and inaccurate detection of disease limits the performance. Hence, this research introduces a privacy-preserving framework named federated learning based diabetic retinopathy detection network (FedDRNet) model. The proposed FedDRNet model includes efficient cross stage recurrent network (ECSRNet) for training the local and server model that combines the strengths of ShuffleNet, CSPNet, and GRU to achieve high accuracy and computational efficiency. Besides, to strengthen the privacy, Homomorphic Encryption is applied prior to the update sharing for obtaining secure communication between clients and the central server. Also, improved K-means clustering (IKMC) based user selection enhances the communication efficiency by reducing the communication rounds. The analysis of FedDRNet by implementing in PYTHON programming tool based on Accuracy, Precision, Recall, F-Score, and Specificity acquired the values of 98.6, 98.8, 98.3, 98.6, and 98.1% respectively.

Indexed as

Diabetic RetinopathyPrivacyAlgorithmsComputer SecurityDeep LearningFederated LearningHumansClient clustering modelCross stage partial networkDiabetic retinopathyFederated learningHomomorphic encryptionMulti-scale filteringNoise removalPrivacy-preservationShuffleNet

Identifiers

PMID41136513
PMCPMC12552717

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.